Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Calls for Farm Bill 'Centered on Innovation'
November 15, 2022
The next farm bill offers an opportunity to examine innovation’s influence on the resiliency of our economy in the face of global challenges, BIO wrote in a statement for the record to the Senate Agriculture Committee's Nov. 15 hearing on energy and…
BIO Announces Beth Ellikidis as Vice President, Agriculture and Environment
November 14, 2022
The Biotechnology Innovation Organization (BIO) is pleased to announce that Beth Ellikidis has joined BIO as Vice President, Agriculture and Environment. In her role, Beth will lead the policy and market access strategies for BIO’s Agriculture and…
BIO Announces 2022 Impact Awards
November 3, 2022
Awards Recognize Innovators in Agricultural, Environmental and Industrial Biotechnology   The Biotechnology Innovation Organization today announced Dr. Annie Tsong, chief strategy & product officer at Amyris, as the winner of this year’s…
BIO: Mexico's Biotech Corn Ban Will Cause Food Security Crisis
October 28, 2022
Washington, D.C. (October 28, 2022) – BIO is disappointed to hear Mexico intends to proceed with its plan to arbitrarily restrict imports of biotech corn. While Mexico states that Brazil, Argentina, and other countries may appear to be alternative…
Biotech Sector Thrives, Generating Nearly $3 Trillion Economic Impact – New Report Shows
October 26, 2022
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States.The new report, The U.S. Bioscience Industry: Fostering Innovation and…
BIO encourages Administration to "bring transparency to the broken rebate system"
October 14, 2022
After the White House announced plans to sign an Executive Order directing the Department of Health and Human Services (HHS)  to explore additional actions to lower prescription drug costs, Nick Shipley, Chief Advocacy Officer at the…
Established Industry Leader Rachel King will Serve as BIO’s Interim Leader
October 10, 2022
 The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to…
BIO Announces Leadership Update
October 10, 2022
Today, Dr. Michelle McMurry-Heath informed the Biotechnology Innovation Organization (BIO) Executive Committee that she is stepping down from her position as President and Chief Executive Officer effective October 11, 2022, and she has agreed to…
Implications and Consumer Price Impacts of Mexico's Biotech Corn Ban
October 3, 2022
Washington, D.C. (October 3, 2022) – Today, a coalition of leading food and agriculture industry stakeholders in both Mexico and the United States released a new study revealing the broad impacts of Mexico’s proposed ban on biotech corn. The report,…
Announcement of PDUFA Agreement in Congress Supports Biomedical Innovation, Helps Patients
September 22, 2022
Biotechnology Industry Organization (BIO) President and CEO, Dr. Michelle McMurry-Heath, released the following statement following the announcement that Congress reached an agreement on the Prescription Drug User Fee Act (PDUFA): “For 30…